Russia has released a final test of the effectiveness of the vaccine against COVID-19 as being able to provide protection against the disease at a high rate of 92 per cent, and publish the results in a globally recognized medical journal.
Today (3 Feb. 2021), the medical journal The Lancit, published the results of the Sputnik vaccine test. At the Russian Institute of Kamalaya, it was developed to prevent COVID-19 from late-stage testing on 19,866 volunteers performed in Moscow. Since September the past.
The test divided the subjects into two groups: three-quarters of them received the sputnik vaccine and one-fourth received a counterfeit vaccine with no protective effect. Only 16 people received the Sputnik vaccine showing signs of COVID-19 infection, while the counterfeit vaccine group infected 62 people.
The results of such tests show that Two doses of the sputnik vaccine, 21 days apart, were effective in preventing sickness from COVID-19 by 91.6 percent.
It was also found that The vaccine protects against severe illness from COVID-19, but it is not clear whether it can stop transmission. And very low rates of severe side effects of vaccination are still observed. The test was attended by 2,100 people over the age of 60.
Related news
Russia is preparing a massive trial of the Sputnik 5 vaccine for 40,000 people.
– .
